Akero Therapeutics Inc (NASDAQ:AKRO)

49.09
Delayed Data
As of 3:39pm ET
 +0.35 / +0.72%
Today’s Change
7.52
Today|||52-Week Range
54.88
-10.42%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2017

2018

--

--
Revenue and IncomeNet Revenues0.000.00------
 
Operating ExpensesGross Income0.000.00------
General Expenses4.6M13.8M----
 
 
 
Research And Development3.5M11.9M----
 
 
 
Total Operating Expenses4.6M13.8M----
 
 
 
 
Non-Operating ExpensesOperating Income-4.6M-13.8M----
 
 
 
Extraordinary Charge0.00-67.9M----
 
 
Other Expenses0.00-21.0K----
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.6M-81.7M----
 
 
 
Preferred Dividend-213.0K-520.0K----
 
 
 
Net Income-4.6M-81.7M----
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS--27.0M----
 
 
Shares To Calculate EPS Diluted--27.0M----
 
 
 
Earnings Per ShareEPS---$3.04----
 
 
EPS Diluted---$3.04----